ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Herpes Zoste Drug Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-23U9617
Home | Market Reports | Health| Pharmacy
Global Herpes Zoste Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Herpes Zoste Drug Market Research Report 2025

Code: QYRE-Auto-23U9617
Report
January 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astellas Pharma Inc
Beijing Minhai Biotechnology Co Ltd
ContraVir Pharmaceuticals, Inc.
Epiphany Biosciences Inc
Foamix Pharmaceuticals Ltd
GeneOne Life Science Inc
GlaxoSmithKline PLC
Merck& Co. Inc
NAL Pharmaceuticals Ltd.
ReceptoPharm, Inc.
TSRL

Herpes Zoste Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Herpes Zoste Drug Market

Herpes Zoste Drug Market

The global market for Herpes Zoste Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Herpes Zoste Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Zoste Drug.
The Herpes Zoste Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Herpes Zoste Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herpes Zoste Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Herpes Zoste Drug Market Report

Report Metric Details
Report Name Herpes Zoste Drug Market
CAGR 5%
Segment by Type
  • Acyclovir
  • Amenamevir
  • FV-100
  • GLS-5100
  • GSK-1437173A
  • NAL-3221
  • Others
Segment by Application
  • Clinic
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd, ContraVir Pharmaceuticals, Inc., Epiphany Biosciences, Inc., Foamix Pharmaceuticals Ltd., GeneOne Life Science, Inc., GlaxoSmithKline Plc, Merck & Co., Inc., NAL Pharmaceuticals Ltd., ReceptoPharm, Inc., TSRL, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Herpes Zoste Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Herpes Zoste Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Herpes Zoste Drug Market report?

Ans: The main players in the Herpes Zoste Drug Market are Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd, ContraVir Pharmaceuticals, Inc., Epiphany Biosciences, Inc., Foamix Pharmaceuticals Ltd., GeneOne Life Science, Inc., GlaxoSmithKline Plc, Merck & Co., Inc., NAL Pharmaceuticals Ltd., ReceptoPharm, Inc., TSRL, Inc.

What are the Application segmentation covered in the Herpes Zoste Drug Market report?

Ans: The Applications covered in the Herpes Zoste Drug Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Herpes Zoste Drug Market report?

Ans: The Types covered in the Herpes Zoste Drug Market report are Acyclovir, Amenamevir, FV-100, GLS-5100, GSK-1437173A, NAL-3221, Others

Recommended Reports

Infectious Disease Drugs

Autoimmune & Allergy Therapies

Drug Safety & Delivery

1 Herpes Zoste Drug Market Overview
1.1 Product Definition
1.2 Herpes Zoste Drug by Type
1.2.1 Global Herpes Zoste Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Acyclovir
1.2.3 Amenamevir
1.2.4 FV-100
1.2.5 GLS-5100
1.2.6 GSK-1437173A
1.2.7 NAL-3221
1.2.8 Others
1.3 Herpes Zoste Drug by Application
1.3.1 Global Herpes Zoste Drug Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Herpes Zoste Drug Market Size Estimates and Forecasts
1.4.1 Global Herpes Zoste Drug Revenue 2020-2031
1.4.2 Global Herpes Zoste Drug Sales 2020-2031
1.4.3 Global Herpes Zoste Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Herpes Zoste Drug Market Competition by Manufacturers
2.1 Global Herpes Zoste Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Herpes Zoste Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Herpes Zoste Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Herpes Zoste Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Herpes Zoste Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Herpes Zoste Drug, Product Type & Application
2.7 Global Key Manufacturers of Herpes Zoste Drug, Date of Enter into This Industry
2.8 Global Herpes Zoste Drug Market Competitive Situation and Trends
2.8.1 Global Herpes Zoste Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Herpes Zoste Drug Players Market Share by Revenue
2.8.3 Global Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Herpes Zoste Drug Market Scenario by Region
3.1 Global Herpes Zoste Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Herpes Zoste Drug Sales by Region: 2020-2031
3.2.1 Global Herpes Zoste Drug Sales by Region: 2020-2025
3.2.2 Global Herpes Zoste Drug Sales by Region: 2026-2031
3.3 Global Herpes Zoste Drug Revenue by Region: 2020-2031
3.3.1 Global Herpes Zoste Drug Revenue by Region: 2020-2025
3.3.2 Global Herpes Zoste Drug Revenue by Region: 2026-2031
3.4 North America Herpes Zoste Drug Market Facts & Figures by Country
3.4.1 North America Herpes Zoste Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Herpes Zoste Drug Sales by Country (2020-2031)
3.4.3 North America Herpes Zoste Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Herpes Zoste Drug Market Facts & Figures by Country
3.5.1 Europe Herpes Zoste Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Herpes Zoste Drug Sales by Country (2020-2031)
3.5.3 Europe Herpes Zoste Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Herpes Zoste Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Herpes Zoste Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Herpes Zoste Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Herpes Zoste Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Herpes Zoste Drug Market Facts & Figures by Country
3.7.1 Latin America Herpes Zoste Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Herpes Zoste Drug Sales by Country (2020-2031)
3.7.3 Latin America Herpes Zoste Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Herpes Zoste Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Herpes Zoste Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Herpes Zoste Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Herpes Zoste Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Herpes Zoste Drug Sales by Type (2020-2031)
4.1.1 Global Herpes Zoste Drug Sales by Type (2020-2025)
4.1.2 Global Herpes Zoste Drug Sales by Type (2026-2031)
4.1.3 Global Herpes Zoste Drug Sales Market Share by Type (2020-2031)
4.2 Global Herpes Zoste Drug Revenue by Type (2020-2031)
4.2.1 Global Herpes Zoste Drug Revenue by Type (2020-2025)
4.2.2 Global Herpes Zoste Drug Revenue by Type (2026-2031)
4.2.3 Global Herpes Zoste Drug Revenue Market Share by Type (2020-2031)
4.3 Global Herpes Zoste Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Herpes Zoste Drug Sales by Application (2020-2031)
5.1.1 Global Herpes Zoste Drug Sales by Application (2020-2025)
5.1.2 Global Herpes Zoste Drug Sales by Application (2026-2031)
5.1.3 Global Herpes Zoste Drug Sales Market Share by Application (2020-2031)
5.2 Global Herpes Zoste Drug Revenue by Application (2020-2031)
5.2.1 Global Herpes Zoste Drug Revenue by Application (2020-2025)
5.2.2 Global Herpes Zoste Drug Revenue by Application (2026-2031)
5.2.3 Global Herpes Zoste Drug Revenue Market Share by Application (2020-2031)
5.3 Global Herpes Zoste Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Astellas Pharma Inc.
6.1.1 Astellas Pharma Inc. Company Information
6.1.2 Astellas Pharma Inc. Description and Business Overview
6.1.3 Astellas Pharma Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Astellas Pharma Inc. Herpes Zoste Drug Product Portfolio
6.1.5 Astellas Pharma Inc. Recent Developments/Updates
6.2 Beijing Minhai Biotechnology Co., Ltd
6.2.1 Beijing Minhai Biotechnology Co., Ltd Company Information
6.2.2 Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
6.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Portfolio
6.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates
6.3 ContraVir Pharmaceuticals, Inc.
6.3.1 ContraVir Pharmaceuticals, Inc. Company Information
6.3.2 ContraVir Pharmaceuticals, Inc. Description and Business Overview
6.3.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Portfolio
6.3.5 ContraVir Pharmaceuticals, Inc. Recent Developments/Updates
6.4 Epiphany Biosciences, Inc.
6.4.1 Epiphany Biosciences, Inc. Company Information
6.4.2 Epiphany Biosciences, Inc. Description and Business Overview
6.4.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Product Portfolio
6.4.5 Epiphany Biosciences, Inc. Recent Developments/Updates
6.5 Foamix Pharmaceuticals Ltd.
6.5.1 Foamix Pharmaceuticals Ltd. Company Information
6.5.2 Foamix Pharmaceuticals Ltd. Description and Business Overview
6.5.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio
6.5.5 Foamix Pharmaceuticals Ltd. Recent Developments/Updates
6.6 GeneOne Life Science, Inc.
6.6.1 GeneOne Life Science, Inc. Company Information
6.6.2 GeneOne Life Science, Inc. Description and Business Overview
6.6.3 GeneOne Life Science, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GeneOne Life Science, Inc. Herpes Zoste Drug Product Portfolio
6.6.5 GeneOne Life Science, Inc. Recent Developments/Updates
6.7 GlaxoSmithKline Plc
6.7.1 GlaxoSmithKline Plc Company Information
6.7.2 GlaxoSmithKline Plc Description and Business Overview
6.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Product Portfolio
6.7.5 GlaxoSmithKline Plc Recent Developments/Updates
6.8 Merck & Co., Inc.
6.8.1 Merck & Co., Inc. Company Information
6.8.2 Merck & Co., Inc. Description and Business Overview
6.8.3 Merck & Co., Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck & Co., Inc. Herpes Zoste Drug Product Portfolio
6.8.5 Merck & Co., Inc. Recent Developments/Updates
6.9 NAL Pharmaceuticals Ltd.
6.9.1 NAL Pharmaceuticals Ltd. Company Information
6.9.2 NAL Pharmaceuticals Ltd. Description and Business Overview
6.9.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio
6.9.5 NAL Pharmaceuticals Ltd. Recent Developments/Updates
6.10 ReceptoPharm, Inc.
6.10.1 ReceptoPharm, Inc. Company Information
6.10.2 ReceptoPharm, Inc. Description and Business Overview
6.10.3 ReceptoPharm, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ReceptoPharm, Inc. Herpes Zoste Drug Product Portfolio
6.10.5 ReceptoPharm, Inc. Recent Developments/Updates
6.11 TSRL, Inc.
6.11.1 TSRL, Inc. Company Information
6.11.2 TSRL, Inc. Description and Business Overview
6.11.3 TSRL, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 TSRL, Inc. Herpes Zoste Drug Product Portfolio
6.11.5 TSRL, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Herpes Zoste Drug Industry Chain Analysis
7.2 Herpes Zoste Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Herpes Zoste Drug Production Mode & Process Analysis
7.4 Herpes Zoste Drug Sales and Marketing
7.4.1 Herpes Zoste Drug Sales Channels
7.4.2 Herpes Zoste Drug Distributors
7.5 Herpes Zoste Drug Customer Analysis
8 Herpes Zoste Drug Market Dynamics
8.1 Herpes Zoste Drug Industry Trends
8.2 Herpes Zoste Drug Market Drivers
8.3 Herpes Zoste Drug Market Challenges
8.4 Herpes Zoste Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astellas Pharma Inc
Beijing Minhai Biotechnology Co Ltd
ContraVir Pharmaceuticals, Inc.
Epiphany Biosciences Inc
Foamix Pharmaceuticals Ltd
GeneOne Life Science Inc
GlaxoSmithKline PLC
Merck& Co. Inc
NAL Pharmaceuticals Ltd.
ReceptoPharm, Inc.
TSRL
List of Tables
 Table 1. Global Herpes Zoste Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Herpes Zoste Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Herpes Zoste Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Herpes Zoste Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Herpes Zoste Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Herpes Zoste Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Herpes Zoste Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Herpes Zoste Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Herpes Zoste Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Herpes Zoste Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Herpes Zoste Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Herpes Zoste Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Herpes Zoste Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoste Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Herpes Zoste Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Herpes Zoste Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Herpes Zoste Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Herpes Zoste Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Herpes Zoste Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Herpes Zoste Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Herpes Zoste Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Herpes Zoste Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Herpes Zoste Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Herpes Zoste Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Herpes Zoste Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Herpes Zoste Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Herpes Zoste Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Herpes Zoste Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Herpes Zoste Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Herpes Zoste Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Herpes Zoste Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Herpes Zoste Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Herpes Zoste Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Herpes Zoste Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Herpes Zoste Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Herpes Zoste Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Herpes Zoste Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Herpes Zoste Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Herpes Zoste Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Herpes Zoste Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Herpes Zoste Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Herpes Zoste Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Herpes Zoste Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Herpes Zoste Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Herpes Zoste Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Herpes Zoste Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Herpes Zoste Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Herpes Zoste Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Herpes Zoste Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Herpes Zoste Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Herpes Zoste Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Herpes Zoste Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Herpes Zoste Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Herpes Zoste Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Herpes Zoste Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Herpes Zoste Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Herpes Zoste Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Herpes Zoste Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Herpes Zoste Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Herpes Zoste Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Herpes Zoste Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Herpes Zoste Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Herpes Zoste Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Herpes Zoste Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Herpes Zoste Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Herpes Zoste Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Herpes Zoste Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Herpes Zoste Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Astellas Pharma Inc. Company Information
 Table 71. Astellas Pharma Inc. Description and Business Overview
 Table 72. Astellas Pharma Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Astellas Pharma Inc. Herpes Zoste Drug Product
 Table 74. Astellas Pharma Inc. Recent Developments/Updates
 Table 75. Beijing Minhai Biotechnology Co., Ltd Company Information
 Table 76. Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
 Table 77. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product
 Table 79. Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates
 Table 80. ContraVir Pharmaceuticals, Inc. Company Information
 Table 81. ContraVir Pharmaceuticals, Inc. Description and Business Overview
 Table 82. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product
 Table 84. ContraVir Pharmaceuticals, Inc. Recent Developments/Updates
 Table 85. Epiphany Biosciences, Inc. Company Information
 Table 86. Epiphany Biosciences, Inc. Description and Business Overview
 Table 87. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Epiphany Biosciences, Inc. Herpes Zoste Drug Product
 Table 89. Epiphany Biosciences, Inc. Recent Developments/Updates
 Table 90. Foamix Pharmaceuticals Ltd. Company Information
 Table 91. Foamix Pharmaceuticals Ltd. Description and Business Overview
 Table 92. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product
 Table 94. Foamix Pharmaceuticals Ltd. Recent Developments/Updates
 Table 95. GeneOne Life Science, Inc. Company Information
 Table 96. GeneOne Life Science, Inc. Description and Business Overview
 Table 97. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. GeneOne Life Science, Inc. Herpes Zoste Drug Product
 Table 99. GeneOne Life Science, Inc. Recent Developments/Updates
 Table 100. GlaxoSmithKline Plc Company Information
 Table 101. GlaxoSmithKline Plc Description and Business Overview
 Table 102. GlaxoSmithKline Plc Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. GlaxoSmithKline Plc Herpes Zoste Drug Product
 Table 104. GlaxoSmithKline Plc Recent Developments/Updates
 Table 105. Merck & Co., Inc. Company Information
 Table 106. Merck & Co., Inc. Description and Business Overview
 Table 107. Merck & Co., Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Merck & Co., Inc. Herpes Zoste Drug Product
 Table 109. Merck & Co., Inc. Recent Developments/Updates
 Table 110. NAL Pharmaceuticals Ltd. Company Information
 Table 111. NAL Pharmaceuticals Ltd. Description and Business Overview
 Table 112. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product
 Table 114. NAL Pharmaceuticals Ltd. Recent Developments/Updates
 Table 115. ReceptoPharm, Inc. Company Information
 Table 116. ReceptoPharm, Inc. Description and Business Overview
 Table 117. ReceptoPharm, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. ReceptoPharm, Inc. Herpes Zoste Drug Product
 Table 119. ReceptoPharm, Inc. Recent Developments/Updates
 Table 120. TSRL, Inc. Company Information
 Table 121. TSRL, Inc. Description and Business Overview
 Table 122. TSRL, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. TSRL, Inc. Herpes Zoste Drug Product
 Table 124. TSRL, Inc. Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Herpes Zoste Drug Distributors List
 Table 128. Herpes Zoste Drug Customers List
 Table 129. Herpes Zoste Drug Market Trends
 Table 130. Herpes Zoste Drug Market Drivers
 Table 131. Herpes Zoste Drug Market Challenges
 Table 132. Herpes Zoste Drug Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Herpes Zoste Drug
 Figure 2. Global Herpes Zoste Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Herpes Zoste Drug Market Share by Type: 2024 & 2031
 Figure 4. Acyclovir Product Picture
 Figure 5. Amenamevir Product Picture
 Figure 6. FV-100 Product Picture
 Figure 7. GLS-5100 Product Picture
 Figure 8. GSK-1437173A Product Picture
 Figure 9. NAL-3221 Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Herpes Zoste Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Herpes Zoste Drug Market Share by Application: 2024 & 2031
 Figure 13. Clinic
 Figure 14. Hospital
 Figure 15. Others
 Figure 16. Global Herpes Zoste Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Herpes Zoste Drug Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Herpes Zoste Drug Sales (2020-2031) & (K Pcs)
 Figure 19. Global Herpes Zoste Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Herpes Zoste Drug Report Years Considered
 Figure 21. Herpes Zoste Drug Sales Share by Manufacturers in 2024
 Figure 22. Global Herpes Zoste Drug Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Herpes Zoste Drug Players: Market Share by Revenue in Herpes Zoste Drug in 2024
 Figure 24. Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Herpes Zoste Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Herpes Zoste Drug Sales Market Share by Country (2020-2031)
 Figure 27. North America Herpes Zoste Drug Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Herpes Zoste Drug Sales Market Share by Country (2020-2031)
 Figure 31. Europe Herpes Zoste Drug Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Herpes Zoste Drug Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Herpes Zoste Drug Revenue Market Share by Region (2020-2031)
 Figure 39. China Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Herpes Zoste Drug Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Herpes Zoste Drug Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Herpes Zoste Drug Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Herpes Zoste Drug Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Herpes Zoste Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Herpes Zoste Drug by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Herpes Zoste Drug by Type (2020-2031)
 Figure 61. Global Herpes Zoste Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Herpes Zoste Drug by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Herpes Zoste Drug by Application (2020-2031)
 Figure 64. Global Herpes Zoste Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Herpes Zoste Drug Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Herpes Infection Treatment Market Research Report 2025
Zoster Vaccine Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Live Attenuated Herpes Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Zoster Vaccine Market Research Report 2025
Global Genital Herpes Treatment Market Research Report 2024
Global Genital Herpes Treatment Drug Market Research Report 2025
Shingles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herpes Labialis Treatment Market Research Report 2024
Cold Sore Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dermatitis Herpetiformis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Genital Herpes Research and Development Pipeline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cold Sore Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Varicella Vaccine Market Research Report 2025
Dermatitis Herpetiformis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Genital Herpes Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poxviridae Infections Drug Market Research Report 2025
Global Scleroderma Treatment Market Research Report 2025
Skin and Soft Tissue Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions